SCHEMBL19559656

SCHEMBL19559656

CCc1oc(=O)oc1COC(COc1ccc(CC2SC(=O)N(N)C2=O)cc1)c1ccccc1F

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.32
FFAR1 O14842 4/20 0.32
PPARA Q07869 2/20 0.32
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6928374 0.85 PPARG (0.48) PPARGFFAR1PPARA
SCHEMBL14213652 0.84 PPARG (0.33) PPARGFFAR1PPARAESR1
SCHEMBL14299359 0.76 FFAR1 (0.32) PPARGFFAR1PPARAESR1
SCHEMBL19217703 0.73 FFAR1 (0.33) PPARGFFAR1
SCHEMBL19559735 0.69 PPARG (0.38) PPARGFFAR1PPARAESR1
SCHEMBL19559694 0.69 PPARG (0.38) PPARGFFAR1PPARAESR1
SCHEMBL19217777 0.68 PPARG (0.40) PPARGFFAR1
SCHEMBL19559726 0.68 PPARG (0.49) PPARGFFAR1
SCHEMBL19559692 0.67 FFAR1 (0.41) PPARGFFAR1ESR1
SCHEMBL19559754 0.67 FFAR1 (0.41) PPARGFFAR1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513070-B1 PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES CIRIUS THERAPEUTICS INC (US) 2017-11-08 EP disclosed